These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37349788)

  • 1. Enhancer-driven transcription of MCM8 by E2F4 promotes ATR pathway activation and glioma stem cell characteristics.
    Sun YM; Zhang YM; Shi HL; Yang S; Zhao YL; Liu HJ; Li C; Liu HL; Yang JP; Song J; Sun GZ; Yang JK
    Hereditas; 2023 Jun; 160(1):29. PubMed ID: 37349788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MCM8 is regulated by EGFR signaling and promotes the growth of glioma stem cells through its interaction with DNA-replication-initiating factors.
    Wang X; Zhang L; Song Y; Jiang Y; Zhang D; Wang R; Hu T; Han S
    Oncogene; 2021 Jul; 40(27):4615-4624. PubMed ID: 34131285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells.
    Gao Z; Xu J; Fan Y; Zhang Z; Wang H; Qian M; Zhang P; Deng L; Shen J; Xue H; Zhao R; Zhou T; Guo X; Li G
    J Exp Clin Cancer Res; 2022 Nov; 41(1):323. PubMed ID: 36380368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway.
    Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L
    FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NFAT1-Mediated Regulation of NDEL1 Promotes Growth and Invasion of Glioma Stem-like Cells.
    Jiang Y; Song Y; Wang R; Hu T; Zhang D; Wang Z; Tie X; Wang M; Han S
    Cancer Res; 2019 May; 79(10):2593-2603. PubMed ID: 30940662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas.
    Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q
    BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA GSCAR promotes glioma stem cell maintenance via stabilizing SOX2 expression.
    Jiang X; Zhang Y; Yuan Y; Jin Z; Zhai H; Liu B; Li Y; Zhang C; Chen M; Shi Y; Yan D; Pu J; Chen Y; Yang C
    Int J Biol Sci; 2023; 19(6):1681-1697. PubMed ID: 37063420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal regulation of integrin β4 and KLF4 promotes gliomagenesis through maintaining cancer stem cell traits.
    Ma B; Zhang L; Zou Y; He R; Wu Q; Han C; Zhang B
    J Exp Clin Cancer Res; 2019 Jan; 38(1):23. PubMed ID: 30658712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The U2AF2 /circRNA ARF1/miR-342-3p/ISL2 feedback loop regulates angiogenesis in glioma stem cells.
    Jiang Y; Zhou J; Zhao J; Zhang H; Li L; Li H; Chen L; Hu J; Zheng W; Jing Z
    J Exp Clin Cancer Res; 2020 Sep; 39(1):182. PubMed ID: 32894165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of glioma stem-like cells with a parthenolide derivative ACT001 through inhibition of AEBP1/PI3K/AKT signaling.
    Hou Y; Sun B; Liu W; Yu B; Shi Q; Luo F; Bai Y; Feng H
    Theranostics; 2021; 11(2):555-566. PubMed ID: 33391492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting A20 decreases glioma stem cell survival and tumor growth.
    Hjelmeland AB; Wu Q; Wickman S; Eyler C; Heddleston J; Shi Q; Lathia JD; Macswords J; Lee J; McLendon RE; Rich JN
    PLoS Biol; 2010 Feb; 8(2):e1000319. PubMed ID: 20186265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the phosphorylation of ATM contributes to radioresistance of glioma stem cells.
    Zhou W; Sun M; Li GH; Wu YZ; Wang Y; Jin F; Zhang YY; Yang L; Wang DL
    Oncol Rep; 2013 Oct; 30(4):1793-801. PubMed ID: 23846672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of Cathepsin L promotes radiosensitivity of glioma stem cells both in vivo and in vitro.
    Wang W; Long L; Wang L; Tan C; Fei X; Chen L; Huang Q; Liang Z
    Cancer Lett; 2016 Feb; 371(2):274-84. PubMed ID: 26706414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CCAAT/enhancer-binding protein delta regulates the stemness of glioma stem-like cells through activating PDGFA expression upon inflammatory stimulation.
    Wang SM; Lin HY; Chen YL; Hsu TI; Chuang JY; Kao TJ; Ko CY
    J Neuroinflammation; 2019 Jul; 16(1):146. PubMed ID: 31300060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. lncRNA TUG1 inhibits the cancer stem cell‑like properties of temozolomide‑resistant glioma cells by interacting with EZH2.
    Cao Y; Chai W; Wang Y; Tang D; Shao D; Song H; Long J
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The U2AF65/circNCAPG/RREB1 feedback loop promotes malignant phenotypes of glioma stem cells through activating the TGF-β pathway.
    Li H; Jiang Y; Hu J; Xu J; Chen L; Zhang G; Zhao J; Zong S; Guo Z; Li X; Zhao X; Jing Z
    Cell Death Dis; 2023 Jan; 14(1):23. PubMed ID: 36635261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma.
    Yang S; Yuan Y; Ren W; Wang H; Zhao Z; Zhao H; Zhao Q; Chen X; Jiang X; Zhang L
    Front Oncol; 2022; 12():1004324. PubMed ID: 36465369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative analysis of a novel super-enhancer-associated lncRNA prognostic signature and identifying LINC00945 in aggravating glioma progression.
    Yang Z; Zheng Y; Wu H; Xie H; Zhao J; Chen Z; Li L; Yue X; Zhao B; Bian E
    Hum Genomics; 2023 Mar; 17(1):33. PubMed ID: 37004060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The miR-26a/AP-2α/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma.
    Huang W; Zhong Z; Luo C; Xiao Y; Li L; Zhang X; Yang L; Xiao K; Ning Y; Chen L; Liu Q; Hu X; Zhang J; Ding X; Xiang S
    Theranostics; 2019; 9(19):5497-5516. PubMed ID: 31534499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
    Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
    Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.